FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 22435552 · Received July 8, 2025

Report

Report Number
1823260-2025-02080
Event Type
Malfunction
Date Received
July 8, 2025
Date of Event
June 4, 2025
Report Date
October 30, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A SERIAL NUMBER OF (B)(6) WAS PROVIDED FOR ONE OF THE C 503 SYSTEMS, BUT IT IS NOT KNOWN IF THIS WAS THE SERIAL NUMBER FOR THE FIRST OR THE SECOND ANALYZER. THE SERIAL NUMBER OF THE OTHER ANALYZER WAS NOT PROVIDED. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

A REVIEW OF ALARM TRACE DATA SHOWED A HIGH FREQUENCY OF SAMPLE RELATED ALARMS. FROM 01-JUL-2025 TO 22-SEP-2025, THERE WERE A TOTAL OF 842 ABNORMAL ASPIRATION ALARMS. CALIBRATION AND CONTROL DATA WERE ACCEPTABLE. THERE WAS NO INDICATION OF A GENERAL REAGENT ISSUE. THE INVESTIGATION DETERMINED THE ISSUE IS CONSISTENT WITH INSUFFICIENT PRE-ANALYTIC SAMPLE HANDLING IN COMBINATION WITH AN ISSUE WITH THE INSTRUMENT'S CELL RINSE FUNCTIONALITY. MEDWATCH FIELDS D1, D2, D4, G1, AND G4 HAVE BEEN UPDATED.

Additional Manufacturer Narrative · 0

THE TRIGLYCERIDES REAGENT LOT NUMBER 851627 WAS USED FOR THE FIRST TWO SAMPLES. THE TRIGLYCERIDES REAGENT LOT NUMBER ON 16-JUN-2025 WAS 861340. THE FIRST SAMPLE WAS TESTED ON 04-JUN-2025. THE SECOND SAMPLE WAS TESTED ON 10-JUN-2025. THE THIRD SAMPLE WAS TESTED ON 16-JUN-2025. MEDWATCH FIELDS B4 AND D4 HAVE BEEN UPDATED.

Description of Event or Problem · 0

THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR THREE PATIENT SAMPLES TESTED WITH THE TRIGLYCERIDES ASSAY ON TWO COBAS C 503 ANALYTICAL UNIT ANALYZERS. THE FIRST SAMPLE INITIALLY RESULTED IN A TRIGLYCERIDES VALUE OF 395 MG/DL WHEN TESTED ON THE FIRST C 503 SYSTEM. WHEN REPEATED ON THE SECOND C 503 SYSTEM, IT RESULTED IN A VALUE OF 288 MG/DL. THE SECOND SAMPLE INITIALLY RESULTED IN A TRIGLYCERIDES VALUE OF 350 MG/DL AND IT REPEATED AS 105 MG/DL WHEN TESTED ON THE SECOND C 503 SYSTEM. THE THIRD SAMPLE INITIALLY RESULTED IN A TRIGLYCERIDES VALUE OF 307 MG/DL AND IT REPEATED AS 80.7 WHEN TESTED ON THE SECOND C 503 SYSTEM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
387525 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS 851627, 861340

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown